OOIR: Observatory of International Research

Papers

(The H4-Index of Autoimmunity Reviews is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	212
Editorial Board	163
Comment on “Meta-analysis of meteorological conditions and rheumatoid arthritis”	135
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives	123
The Trm-Treg Axis as a tissue-encoded immune checkpoint in chronic inflammation and autoimmunity	123
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	112
The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies	110
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	106
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	105
Endometriosis and autoimmunity	98
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	98
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	95
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	94
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	86
Autoantibody internalization in myositis skeletal muscle: Emerging evidence, mechanistic insights, and therapeutic relevance	85
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	80
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	72
Metabolic traits of T cells and the implications in autoimmune diseases	70
Can anticoagulation be withdrawn in APS patients after aPL negativization?	69
Editorial Board	69
Psychiatric manifestations of autoimmune encephalitis	69
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	64
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	64
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	63
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	61

Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	61
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	61
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	59
Autoimmune pre-disease	59
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis	58
STING-inflammasome axis in autoimmune diseases and inflammation-related disease	57
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	56
Dysregulation of helper, regulatory, and follicular CD4+ T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy	55
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	54
Autoimmunity, diet and autophagy	52
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	51
Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies	51
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	51
Seronegative autoimmune diseases: A challenging diagnosis	49
Editorial Board	49
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	48
Editorial Board	47
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	47
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	45
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	45
Adipose failure through adipocyte overload and autoimmunity	45
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	45